Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
This study has been completed.
Study NCT00003038 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: July 23, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Adrenocortical Carcinoma
Breast Cancer
Colorectal Cancer
Prostate Cancer
Additional conditions recognized in this trial
Breast Neoplasms
Carcinoma
Colorectal Neoplasms
Neoplasms
Prostatic Neoplasms
More general conditions related to this trial
Adenocarcinoma
Adrenal Cortex Diseases
Adrenal Cortex Neoplasms
Adrenal Gland Diseases
Adrenal Gland Neoplasms
Breast Diseases
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Genital Diseases, Male
Genital Neoplasms, Male
Intestinal Diseases
Intestinal Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Prostatic Diseases
Rectal Diseases
Skin Diseases
Urogenital Neoplasms
Interventions listed in this trial
doxorubicin hydrochloride
suramin
Additional drug interventions recognized in this trial
Doxorubicin
More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Antibiotics, Antineoplastic
Antinematodal Agents
Antineoplastic Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Trypanocidal Agents
Sponsors listed in this trial
Mayo Clinic
National Cancer Institute (NCI)
Back to top of Main Content
